Drug Type Small molecule drug |
Synonyms ND 004 (NewDEL Biotech), ND004 (NewDEL Biotech) |
Target |
Action modulators |
Mechanism HPK1 modulators(Mitogen-activated protein kinase kinase kinase kinase 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | China | 01 Aug 2026 |





